On-dose authentication technology can help deter counterfeiters, while also helping patients better engage with their medicines.

When it comes to delivering medicines to patients in need, choosing the right packaging partner can make all the difference.

The EMA has given the nod to Ronapreve and Regkirona, two monoclonal antibody treatments for COVID-19.

Applying advanced technologies to bioprocessing operations will only help improve success rates.

How RNA is making waves in the industry – and leading to new research projects and increased demand for new manufacturing capacities.

Jan Cools of the VIB Center for Cancer Biology discusses his experience with Mission Bio’s new DNA sequencing platform.

Antibody drug conjugates are starting to transform cancer treatments, so let’s maintain the momentum.

After a madcap back and forth between leading and dissenting Democrats, Biden’s drug pricing reform plans have reached a compromised final form.

Stating an intention to be ready to win in any biowarzone, the US military has commissioned Dynavax to develop a vaccine for the plague.

In a market filled with complexity, working with a single supplier simplifies the supply chain and focuses effort towards a single target.